Apogenix GmbH
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease (NCT05639192) | Apogenix GmbH | 2022-11-03 |
Track Apogenix GmbH automatically
Every clearance here is in the API, with alerts when new ones post.